SINGAPORE: Two Japanese firms are providing and outlay of US$594mil to buy out local traditional Chinese medicine maker Eu Yan Sang.

       Japanese trading house Mitsui & Co announced on April 4 that a special purpose entity it has set up with Rohto Pharmaceutical will buy around 86% of Eu Yan Sang from Righteous Crane Holding.